Centro Oftalmologico Dr. Charles S.A

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Macular degeneration3 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Apellis Pharmaceuticals, Inc.1 trial
• Ocular Therapeutix, Inc.1 trial
• Sitala Bio LTD1 trial

Running trials

• Recruiting

  A Study in Adults With Geographic Atrophy

  NCT07606365· Phase 2· Sitala Bio LTD· Source

  Contact: Clinical Operations Manager

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

  NCT06223958· Phase 3· Ocular Therapeutix, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source